Details for New Drug Application (NDA): 210071
✉ Email this page to a colleague
The generic ingredient in CELECOXIB is celecoxib. There are twenty-six drug master file entries for this compound. Sixty-four suppliers are listed for this compound. Additional details are available on the celecoxib profile page.
Pharmacology for NDA: 210071
Mechanism of Action | Cyclooxygenase Inhibitors |
Medical Subject Heading (MeSH) Categories for 210071
Suppliers and Packaging for NDA: 210071
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CELECOXIB | celecoxib | CAPSULE;ORAL | 210071 | ANDA | A-S Medication Solutions | 50090-6577 | 50090-6577-0 | 30 CAPSULE in 1 BOTTLE (50090-6577-0) |
CELECOXIB | celecoxib | CAPSULE;ORAL | 210071 | ANDA | A-S Medication Solutions | 50090-6577 | 50090-6577-1 | 60 CAPSULE in 1 BOTTLE (50090-6577-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 50MG | ||||
Approval Date: | Jan 23, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 100MG | ||||
Approval Date: | Jan 23, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 200MG | ||||
Approval Date: | Jan 23, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription